Antacid Market Scope And Analysis

  • Report Code : TIPRE00016359
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 182
Buy Now

Antacid Market Scope and Analysis Report by 2027

Buy Now

Antacid Market Report Antacid Market Size and Share Antacid Market Scope and Analysis

Antacid Market Report Scope

Report Attribute Details
Market size in 2019 US$ 8.55 Billion
Market Size by 2027 US$ 11.67 Billion
Global CAGR (2019 - 2027) 4.0%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Dosage Form
  • Tablet
  • Liquid
By Drug Class
  • Proton pump inhibitors
  • H2 Antagonist
  • Acid neutralizers
By Distribution Channel
  • Hospital pharmacy
  • Retail pharmacy
  • Online pharmacy
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Bayer AG
  • GlaxoSmithKline plc
  • Takeda Pharmaceutical Company Limited
  • Sun Pharmaceutical Industries Ltd
  • Sanofi
  • Boehringer Ingelheim International GmbH
  • Dr Reddy s Laboratories
  • Pfizer Inc
  • Reckitt Benckiser Group Plc

    • Key Market Players:

    • Bayer AG (Germany)
    • GlaxoSmithKline plc (UK)
    • Takeda Pharmaceutical Company Limited (Japan)
    • Sun Pharmaceutical Industries Ltd (India)
    • Sanofi (France)
    • Boehringer Ingelheim International GmbH (Germany)
    • Dr. Reddy's Laboratories (India)
    • Pfizer Inc (US)
    • Reckitt Benckiser Group Plc (UK)
    • Procter & Gamble (US)

    Key Developments in Antacid Market:

    • June 2018:

      GlaxoSmithKline plc acquired about 36.5% stake from Novartis for an estimated value of US$ 13 billion. The acquisition helped the company strengthen its consumer healthcare business worldwide.

    • August 2020:

      Takeda Pharmaceutical Company Limited declared to divest Takeda Consumer Healthcare Company Limited, a wholly owned subsidiary of Takeda operating in Japan, to the Blackstone Group Inc.

    • May 2017:

      Pfizer Limited (India) acquired AstraZeneca AB’s brand, Neksium, in India. The deal was valued at around Rs. 75 crores. Neksium is an antacid containing Esomeprazole as an API.

    Report Coverage

    The global antacid market research report delivers a detailed analysis of the OTC drugs in terms of market size, share, trends, and forecasts. The report provides crisp and precise insights of drivers, restraints, opportunities, segments, and industrial landscape. The impact of COVID-19 is elaborated with the aftermath observed in global and regional markets. The segmental analysis features the dominant markets with respective revenue shares and annual growth rates.